Latest filing published 15 Sept 2026 for Mirum Pharmaceuticals, Inc., €844k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Eric Bjerkholt is a declared insider at 2 companies; the most frequent names are Mirum Pharmaceuticals, Inc. and Cerus Corp. Between 8 June 2026 and 14 September 2026, the trades on record add up to 5 filings.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 15 September 2026 with a transaction (€844k) in Mirum Pharmaceuticals, Inc. The median gap between trade and publication is zero days: most filings appear on the same day. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations